As abnormal constitutive NF-κB activation plays an important role in controlling T-ALL cell proliferation (Kordes et al, 2000), we hypothesized that IL-18 may activate NF-κB. The gene discussed is NFKB1; the disease is acute lymphoblastic leukemia.